Provided by Tiger Fintech (Singapore) Pte. Ltd.

GlycoMimetics

0.1938
-0.0048-2.42%
Post-market: 0.1810-0.0128-6.60%19:59 EDT
Volume:58.70M
Turnover:14.63M
Market Cap:12.51M
PE:-0.42
High:0.2118
Open:0.2085
Low:0.1774
Close:0.1986
Loading ...

GlycoMimetics Stockholders Approve Merger with Crescent Biopharma and 1-for-100 Reverse Stock Split

Reuters
·
06 Jun

GlycoMimetics Inc - Reverse Stock Split to Reduce Outstanding Shares to 0.6 Mln

THOMSON REUTERS
·
06 Jun

GlycoMimetics Inc - Board Approves 1-for-100 Reverse Stock Split

THOMSON REUTERS
·
06 Jun

GlycoMimetics Stockholders Approve Proposed Merger With Crescent Biopharma and All Related Proposals

THOMSON REUTERS
·
06 Jun

GlycoMimetics Updates Merger Agreement with Crescent Biopharma, Amends Terms for Third Time

Reuters
·
30 May

GlycoMimetics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
17 May

GlycoMimetics Inc expected to post a loss of 5 cents a share - Earnings Preview

Reuters
·
05 May

GlycoMimetics Initiated at Overweight by Cantor Fitzgerald

Dow Jones
·
21 Mar

Cantor Fitzgerald Initiates GlycoMimetics at Overweight

MT Newswires Live
·
21 Mar

BRIEF-GlycoMimetics Says Following Termination, Co Will Not Have Any Material Financial Or Other Obligations Under Agreement

Reuters
·
26 Feb

GlycoMimetics : on Feb 19, Received Notice From Apollomics (Hong Kong) Limited Terminating Collaboration and License Agreement

THOMSON REUTERS
·
26 Feb

GlycoMimetics : Following Termination, Co Will Not Have Any Material Financial or Other Obligations Under Agreement

THOMSON REUTERS
·
26 Feb

GlycoMimetics Inc - Amended Agreement for $200 Million Purchase of Crescent Securities

THOMSON REUTERS
·
15 Feb

GlycoMimetics Inc - Co and Crescent Biopharma Amend Merger Agreement

THOMSON REUTERS
·
15 Feb

BRIEF-Glycomimetics Inc Says CEO Harout Semerjian And CFO Brian Hahn To Step Down

Reuters
·
01 Feb

GlycoMimetics Inc - CEO Harout Semerjian and CFO Brian Hahn to Step Down

THOMSON REUTERS
·
01 Feb

GlycoMimetics and Crescent Biopharma Announce Merger Plans

TipRanks
·
14 Jan

BRIEF-GlycoMimetics On Dec 19 Nasdaq Grants Glycomimetics 180 Days To Regain Compliance

Reuters
·
27 Dec 2024

GlycoMimetics Inc - on Dec 19, Nasdaq Grants GlycoMimetics 180 Days to Regain Compliance

THOMSON REUTERS
·
27 Dec 2024